acute myeloid leukemia

MaaT Pharma Releases Results Of Microbiome Restoration Therapy in Acute Myeloid Leukemia Patients
Fri, 11/2/18 - 09:34 am
MaaT Pharma
acute myeloid leukemia
microbiome
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CP Wire
Thu, 09/27/18 - 10:09 am
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
Thu, 09/27/18 - 09:57 am
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia
CP Wire
Mon, 08/27/18 - 10:56 pm
Bio-Path Holdings
prexigebersen
acute myeloid leukemia
clinical trials
Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia
Mon, 08/27/18 - 09:49 am
Bio-Path Holdings
prexigebersen
acute myeloid leukemia
Agios scores its second new drug approval, ivosidenib heads to the AML market
Endpoints
Fri, 07/20/18 - 11:52 am
Agios Pharmaceuticals
ivosidenib (AG-120)
AML
acute myeloid leukemia
FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia
CP Wire
Wed, 06/27/18 - 09:57 am
Pfizer
glasdegib
acute myeloid leukemia
FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia
Wed, 06/27/18 - 09:49 am
Pfizer
glasdegib
acute myeloid leukemia
Intellia Therapeutics Announces WT1 for treating Acute Myeloid Leukemia as Its First Cell Therapy Target
Thu, 05/17/18 - 09:41 am
Intellia Therapeutics
acute myeloid leukemia
BioLineRx Receives European Patent Covering BL-8040 with Cytarabine for Acute Myeloid Leukemia
CP WIre
Wed, 05/16/18 - 09:15 am
Bioline Rx
acute myeloid leukemia
BL-8040
Europe
BioLineRx Receives European Patent Covering BL-8040 with Cytarabine for Acute Myeloid Leukemia
Wed, 05/16/18 - 09:14 am
Bioline Rx
acute myeloid leukemia
BL-8040
Daiichi Sankyo in pursuit of Novartis’ Rydapt with next-generation FLT3 drug
Fierce Biotech
Wed, 05/9/18 - 09:21 am
Novartis
Rydapt
acute myeloid leukemia
Daiichi Sankyo
quizartinib
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
Wed, 05/2/18 - 10:53 am
Aptevo
APVO436
acute myeloid leukemia
myelodysplastic syndrome
Here's Why GlycoMimetics Could Become a Takeover Target
Yahoo/Motley Fool
Sun, 12/17/17 - 11:36 am
GlycoMimetics
M&A
GMI-1271
AML
acute myeloid leukemia
Pfizer
Innate shares crushed on second big setback for Bristol-Myers partnered lirilumab
Endpoints
Sat, 11/25/17 - 12:32 pm
Innate Pharma
Bristol-Myers Squibb
lirilumab
acute myeloid leukemia
J&J is jettisoning two of its promised blockbuster drugs, and it couldn’t come at a worse time
Endpoints
Tue, 10/17/17 - 10:26 am
JNJ
sirukumab
rheumatoid arthritis
talacotuzumab
acute myeloid leukemia
FDA Approves Pfizer’s Mylotarg 7 Years After it was Pulled From the Market
RAPS.org
Fri, 09/1/17 - 04:06 pm
Pfizer
FDA
Mylotarg
acute myeloid leukemia
AML
Idhifa approval furthers Celgene's diversification goals
BioPharma Dive
Tue, 08/1/17 - 10:54 pm
Celgene
Idhifa
acute myeloid leukemia
Years after accelerated approval debacle, FDA panel backs Pfizer's Mylotarg
Fierce Pharma
Wed, 07/12/17 - 12:05 am
FDA
Pfizer
Mylotarg
acute myeloid leukemia
FDA padlocks any new human tests on Seattle Genetics’ cancer drug in the wake of more deaths
Endpoints
Thu, 06/22/17 - 09:38 am
FDA
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia

Pages